摘要
1文献来源Mittendorf EA,Zhang H,Barrios C H,et al.Neoadjuvant atezolizumab in combination with sequential nab⁃paclitaxel and anthracycline⁃based chemotherapy versus placebo and chemotherapy in patients with early stage triple⁃negative breast cancer(IMpassion031):A randomized,double⁃blind,phase 3 trial[J].Lancet,2020,396(10257):1090-1100.
作者
林雨翔
宋传贵
袁娇媚
LIN Yu-xiang;SONG Chuan-gui;YUAN Jiao-mei(Department of Breast Surgery,Fujian Medical University Union Hospital,Fuzhou 350001,China)
出处
《循证医学》
2021年第2期79-82,共4页
The Journal of Evidence-Based Medicine
关键词
三阴性乳腺癌
新辅助治疗
免疫治疗
阿替利珠单抗
triple⁃negative breast cancer
neoadjuvant therapy
immunotherapy
atezolizumab
